Answer
It is licensed for selected progressive, well-differentiated, somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours in adults that cannot be removed surgically or have spread.
Sources for this answer
- Lutathera 370 MBq/mL solution for infusionemc · SmPC Current selected SmPC · Version 8